ACT 2 Logo
Hormone Optimization

Hormone Optimization · Women

Hormone Replacement Therapy for Women

Perimenopause and menopause shift estrogen and progesterone — and with them, sleep, mood, energy, bone health, and comfort. Hormone therapy, prescribed and monitored correctly, is a well-established way to manage these changes.

The difference is in the precision: we build your plan from labs, then adjust it over time.

From $399 first month, $149/month afterSee full pricing
See if you're eligibleA short assessment. Reviewed by a clinician.
Medically reviewed by Vanessa Niles, R.N., M.D., F.A.C.O.G. August 26, 2026

We measure first. Then we act.

If you were told years ago that hormone therapy carried serious risks — that it caused breast cancer, heart disease, dementia — you were told what the label said at the time.

For a great many women in their forties, fifties and sixties, what follows reopens a conversation they were told to stop having. This page is about what hormone therapy actually involves now, what it can and can't do, and how to decide whether it fits you.

If the question is still whether this is the transition at all, what perimenopause actually does covers the symptom picture and what else is worth excluding first.

What changed
The FDA removed the boxed warnings in February 2026. The labeling changes struck the cardiovascular disease, breast cancer and probable dementia warnings from menopausal hormone therapy products. The agency pointed to randomized evidence that women who start hormone therapy within roughly ten years of menopause show reduced all-cause mortality and fewer fractures.
Feb 2026
When the FDA approved the labeling change
3
Boxed warnings struck — cardiovascular disease, breast cancer, probable dementia
~10 yrs
The window after menopause where the balance looks most favorable
The 2026 change

What the label change does and doesn't mean

What it means: the warning that shaped two decades of advice — originating in the Women's Health Initiative results of the early 2000s — no longer appears on these products. Subsequent analysis showed the original findings were driven substantially by the age of the women studied, most of whom started therapy well after menopause. For women starting closer to the transition, the balance looks materially different.

What it doesn't mean: that hormone therapy is risk-free, or right for everyone. Risk still varies by your age, how long since menopause, your personal and family history, and which route you use. A personal history of breast cancer, blood clots or certain cardiovascular conditions still changes the answer.

What's changed is that the conversation can now be proportionate to the actual evidence, rather than shut down by a warning that applied a single blanket caution to every woman and every formulation. If you dismissed HRT years ago on the strength of that warning, it's worth revisiting with someone who can look at your specific history.

Timing

Why timing matters

The evidence points consistently in one direction: starting closer to the menopause transition tends to produce a better risk-benefit balance than starting many years later.

This is sometimes called the timing hypothesis, and it's the single most useful thing to understand when deciding whether to act. Waiting to see whether symptoms resolve on their own is a reasonable instinct — but for some symptoms, particularly genitourinary ones, they don't resolve, and the window in which starting is most favorable doesn't stay open indefinitely.

That isn't a reason to rush. It is a reason not to treat “I'll think about it for a few more years” as a neutral choice.
Measure first

What we measure first

Before any prescription, we establish a baseline. It tells us what's changing, what to address, and which delivery method fits your life — and sometimes it tells us the cause is not hormonal at all. Estrogen and progesterone are usually considered together; the right form and dose are individual.
  • Hormone panelEstrogen, progesterone and related hormones, read against where you are in the transition.
  • Thyroid functionThyroid dysfunction produces symptoms that look like menopause. Worth ruling out first.
  • Metabolic & lipid pictureThe markers that shape which route is appropriate, and what else may need attention.
  • Iron statusIron deficiency is a common and treatable cause of the fatigue often attributed to menopause.
  • Full historyYour symptoms, your family history, and how long it has been since your last period.
Estrogen

Estrogen therapy options

Prescribed only for eligible patients after clinical evaluation. Results vary. For eligible patients, estrogen therapy may help support relief from menopausal symptoms and bone health. We offer several delivery methods so the plan fits your preferences and physiology.

Products marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.

Progesterone

Progesterone therapy options

For eligible patients, progesterone may help support sleep and cycle-related symptoms — and where you have a uterus and take systemic estrogen, it does something more important: it protects the uterine lining. That is not an optional addition, and oral micronized progesterone is the route with the established evidence for it.

Products marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.

Routes

Choosing a delivery route

Estrogen delivery routes available at ACT 2 Health, compared
PatchTopical / CreamOral capsuleVaginal (local)
Available at ACT 2YesYesYesYes
Treats whole-body symptomsYesYesYesNo — local only
Treats genitourinary symptomsPartlyPartlyPartlyYes — directly
How it's usedWorn and changed on a scheduleApplied to skinSwallowedApplied locally
Risk of transferring to othersMinimalYes — skin contactNonePossible
Level patternSteadiestFairly steadyMore variableLocal, minimal systemic
ConvenienceHighest — set and forgetDaily routineDaily routineOngoing
Best suited toWomen who want low maintenanceWomen who prefer to control applicationWomen who prefer no skin applicationDryness, discomfort with sex, urinary symptoms

Scroll the table sideways to compare →

The honest summary: route is a genuine clinical decision, not just preference — the routes don't behave identically, and your history influences which is more appropriate. But among reasonable options, the one you'll use consistently wins. Many women use a systemic route and a local one, which is a normal combination rather than doubling up.

Explore the individual options: estradiol topical, estradiol patch, estradiol cream, progesterone capsule, progesterone cream and estriol vaginal cream. Your clinician selects the specific preparation as part of your plan.

Eligibility

Who this isn't right for

Read this part

Hormone therapy generally isn't appropriate with undiagnosed vaginal bleeding, active breast or endometrial cancer, active liver disease, or a history of certain blood clots or strokes. A personal history of breast cancer is a nuanced discussion increasingly held jointly with oncology rather than an automatic no — but it is a real conversation, not a formality.

Any bleeding after menopause needs evaluation, regardless of whether you're on hormone therapy. That's not a warning specific to HRT; it's true generally.

Ongoing care

What ongoing care looks like

This is where a program differs from a prescription, and it's most of what you're paying for after the first visit. Three stages, and the third is the one most people are never offered.
  1. 01
    BaselineRelevant hormone levels, thyroid function, a metabolic and lipid picture, iron status, plus a full history covering your symptoms, your family history and where you are in the transition.
  2. 02
    Review on a defined cadenceSymptom relief is the primary measure — not a lab value. Have the hot flashes settled, are you sleeping, has the fog lifted. Adjustments over the first months are normal rather than a sign something went wrong.
  3. 03
    Genuine reassessmentIncluding whether to continue. Current guidance imposes no arbitrary stop date, but it does support revisiting the decision periodically as your circumstances change.
Availability

Where this is available

Hormone therapy for women is available in all 50 states, delivered by telemedicine from clinicians licensed in the state where you're located. See where we're available.

Low noise. High signal.

An honest word on the evidence

Modern hormone therapy is well studied, and current guidance supports it for many women when started within an appropriate window and matched to individual risk. Benefits and risks differ by age, history and route. Three things worth saying plainly.

It isn't a cure for aging: hormone therapy treats the symptoms of hormonal change, it won't reverse everything that shifts in midlife, and anyone selling it as a whole-body reversal is overselling.

It won't fix what isn't hormonal: thyroid dysfunction, iron deficiency, sleep apnea, depression and medication effects all produce symptoms that look like menopause, which is why we measure first — sometimes the more useful outcome is discovering the cause is something else entirely.

And perimenopause is genuinely harder to measure than menopause: hormones fluctuate substantially during the transition, so a single blood draw can look unremarkable on a day when you feel awful. Your clinician reads labs alongside your symptom pattern rather than treating one number as the verdict. See menopause and perimenopause care.

The bigger picture

Where testosterone fits for women

Testosterone often declines in perimenopause too, affecting energy, strength, and libido. Where appropriate, it may be considered alongside estrogen and progesterone — see the full hormone optimization program. Peptides can also complement hormone care; explore peptide therapy for menopause. If weight change is a major part of what you're experiencing, medical weight loss is worth reading alongside this, since the two interact more than either is usually discussed.
Our model

How it works at ACT 2 Health

Every plan follows one path. Each step feeds the next. See the Hormone Optimization approach.

  1. 01

    Measure

    A baseline of labs and history, and a clear read on your goals.

  2. 02

    Plan

    A clinician decides whether it fits — and what to address first.

  3. 03

    Act

    If appropriate, you begin with clear guidance and support.

  4. 04

    Track

    We monitor how you respond on a defined cadence.

  5. 05

    Adjust

    Protocols are refined over time. Guided care, not a kit in the mail.

Questions

Frequently asked questions

  • That warning was removed. In February 2026 the FDA approved labeling changes removing the boxed warnings on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy products, citing evidence that women starting within about ten years of menopause showed reduced all-cause mortality and fewer fractures. Risk still varies by your history and route, but the blanket warning is gone.

  • That depends on how long it's been since menopause and on your history. Evidence suggests starting closer to the transition produces a better balance than starting many years later. It's a genuine clinical conversation rather than a fixed cutoff.

  • That's chosen with your clinician based on your symptoms, history and preference — patch, cream and capsule each behave differently. Among reasonable options, consistency matters most.

  • If you have a uterus, yes. Progesterone protects the uterine lining from unopposed estrogen. It isn't optional where it applies.

  • Your first visit covers the fuller workup and plan build. Refills cover ongoing medication and monitoring once you're established.

  • Sometimes it's considered for energy, strength and libido. It's added only where appropriate and monitored — and it's relevant more often in midlife women than most people assume.

  • Vasomotor symptoms often respond within weeks; sleep and mood can take longer. Adjustments over the first few months are normal rather than a sign of failure.

  • There's no arbitrary stop date in current guidance, but the decision is revisited periodically as your circumstances change. Ongoing rather than indefinite-by-default.

  • Possibly. Hormones fluctuate substantially in perimenopause, so a single draw can look unremarkable on a bad day. Your clinician reads labs alongside your symptom pattern rather than treating one number as the verdict.

  • That depends on your symptoms, preferences, and labs. A clinician helps you choose and adjusts over time.

  • Yes — hormone therapy for women is available in all 50 states, delivered by telemedicine from a clinician licensed where you're located.

References

Government and professional-society sources consulted for this page.

  1. Estrogen and Progestin (Hormone Replacement Therapy)MedlinePlus (U.S. National Library of Medicine)
  2. Hormone Therapy for MenopauseAmerican College of Obstetricians and Gynecologists
  3. The Menopause YearsAmerican College of Obstetricians and Gynecologists
  4. MenopauseMedlinePlus (U.S. National Library of Medicine)

Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.

Own your next chapter

Ready to start with clarity?

We measure first. Then we act.

ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.